CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells

por Morishima, Chihiro, McNeel, Douglas G, Patel, Manish R, Kohrt, Holbrook, Waldmann, Thomas A, Thompson, John A, Conlon, Kevin, M Sondel, Paul, Wakelee, Heather, Disis, Mary L, Creekmore, Stephen P, Miller, Jeffrey S
Publicado 2014